161292-59-7Relevant academic research and scientific papers
TRICYCLIC QUINOXALINEDIONE DERIVATIVES
-
, (2008/06/13)
A tricyclic quinoxalinedione derivative represented by the formula 1: STR1 wherein X represents hydrogen, alkyl, halogen, cyano, trifluoromethyl, or nitro;R 1 represents hydrogen, alkyl, cycloalkyl, or cycloalkylalkyl;G represents--CONR 2--or--NR 2 CO--, wherein R 2 represents hydrogen or alkyl;J represents an acidic group or a group which is convertible thereto in vivo;E represents an basic group or a group which is convertible thereto in vivo;Y represents a single bond, alkylene, alkenylene, substituted alkylene, or Y 1--Q--Y 2, wherein Y 1 represents a single bond or alkylene, Y 2 represents alkylene, and Q represents a heteroatom selected from oxygen or sulfur;Z represents alkylene, or a pharmaceutically acceptable salt thereof, these compounds are selective antagonists of glycine binding site of the NMDA receptor.
Tricyclic indole-2-carboxylic acid derivatives
-
, (2008/06/13)
A tricyclic indole-2-carboxylic acid derivative represented by the formula 1: STR1 wherein X represents alkyl, halogen or cyano;R 1 represents hydrogen, or a protecting group of carboxyl group;W represents hydrogen, --CO 2 R 3i, --CONR 3i R 4i, --A--CO 2 R 3i or --A--CONR 3i R 4i, wherein --A-- represents alkylene and R 3i and R 4i independently represent hydrogen, alkyl, aryl or substituted aryl,or a pharmaceutically acceptable salt thereof, these compounds are selective antagonists of glycine binding site of the NMDA receptor.
